Investor Brief

Communication infrastructure for an overlooked healthcare market

Helping you be understood, not just heard

DysVoxa Neurospeech Platform serves people with dysarthria using identity-preserving speech transformation for work, telehealth, and social communication.

Problem

Dysarthric speakers are often excluded by generic speech AI systems.
Current alternatives either fail on severe articulation patterns or erase speaker identity.
Communication barriers impact employability, care access, and social participation.

Solution

Real-time pipeline: Voice Activity Detection (VAD) -> Automatic Speech Recognition (ASR) -> dysarthria-aware correction -> Text-to-Speech (TTS) -> virtual microphone.
Works with existing apps such as Zoom, Teams, and Meet.
Designed to preserve voice identity while increasing intelligibility.

Market and business model snapshot

Total Addressable Market (TAM)

$10.4B

Serviceable Addressable Market (SAM)

$1.85B

Serviceable Obtainable Market (SOM), Year 5

EUR 54M-108M

Offer	Price	Audience
Early Access (Free)	EUR 0	Backers, supporters & testers only
Individual Pro	EUR 9 / month	Daily personal use
SLP Practices	EUR 80–120 / seat / year	Speech clinics, hospitals, disability services

24-month execution plan

Pilot validation with clinical collaborators and diverse dysarthria phenotypes.
Evidence package expansion with intelligibility and usability outcomes, including legal and reimbursement workstreams.
20+ paying organizations with payer-oriented market entry preparation.
Regulatory and reimbursement readiness for DiGA-aligned strategy.

Funding ask

First campaign on Indiegogo

EUR 60K

Next planned milestone

EUR 2.5M EIC Accelerator trajectory

Why now

A convergence of technological capability, clinical demand, and regulatory clarity makes this the moment for dysarthria-focused AI:

Mature speech tech

Local ASR models are now accurate and fast enough for real-time dysarthria speech. Edge-first architecture runs speech recognition privately on-device; cloud fallback unlocks broader model options where privacy constraints allow.

Digital health acceleration

Post-COVID telehealth adoption is mainstream. Remote communication infrastructure is pervasive, and virtual microphone / OS-level APIs are broadly available.

Regulatory readiness

EU Medical Device Regulation (MDR) Class I pathway is clear for non-diagnostic communication aids. DiGA framework in Germany creates a reimbursement model for digital therapeutics.

Unmet clinical need

SLP networks and neurological centers have been waiting for identity-preserving correction tools. Pilot demand is strong; no credible competitor currently offers recovery-first dysarthria speech enhancement.

The window for a recovery-first, privacy-first dysarthria platform is now. Pre-seed investment will accelerate pilot validation and capture market leadership before the larger assistive tech platforms notice the category.

Investor contact

Share your interest and preferred time window for a call. This form opens your email client.